“Study Of (NF-Κb) Gene Expression As A Biomarker For Development Of Cardiovascular Disease In Type 2 Diabetes”, Journal of Pharmaceutical Negative Results, pp. 599–604, Nov. 2022, doi: 10.47750/pnr.2022.13.S09.66.